Jump to content

Naphyrone

From Wikipedia, the free encyclopedia

This is an old revision of this page, as edited by Rednotdead (talk | contribs) at 13:30, 18 June 2010 (Information on a batch analysis carried out that may have legal implications). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

Naphyrone
Clinical data
ATC code
  • none
Legal status
Legal status
  • Legal in United Kingdom
Identifiers
  • 1-naphthalen-2-yl-2-pyrrolidin-1-ylpentan-1-one
CAS Number
PubChem CID
ChemSpider
CompTox Dashboard (EPA)
Chemical and physical data
FormulaC19H23NO
Molar mass281.391 g/mol g·mol−1
3D model (JSmol)
  • C2CCCN2C(CCC)C(=O)c3cc1ccccc1cc3

Naphyrone (O-2482, NRG-1, Energy 1), also known as naphthylpyrovalerone,[1] is a drug derived from pyrovalerone that acts as a triple reuptake inhibitor,[2] producing stimulant effects and has been reported as a novel designer drug.[3] No safety or toxicity data is available on the drug.[4]

Use in the United Kingdom

Naphyrone is emerging as a new legal high in the United Kingdom only months after the ban of similar drug Mephedrone (which was also a cathinone derivative) - and as a result, the drug has been referred to as the "next meow meow". Currently, the substance is not controlled by the Misuse of Drugs Act 1971 and it is therefore not illegal for someone to possess it. The Medicines Act prevents Naphyrone from being sold for human consumption, and therefore it is sometimes sold as 'Pond Cleaner' or as another substance not normally consumed by humans. In response to this emerging trend of new legal highs, Home Office Minister James Brokenshire has said "Action to address the issue of emerging legal highs coming on to the market is a priority for the Government."[5]

A batch analysis report from the Scottish Drug Forum dated 12th June 2010 [6] confirmed suspicions that at least some products labelled as NRG-1 contain the Class B substance MDPV. In the case of an individual possessing a product labelled NRG-1 that contains MDPV, they are technically in possession of a controlled substance.

Pharmacology

As a triple reuptake inhibitor, naphyrone has been shown in vitro to affect the reuptake of the neurotransmitters serotonin, dopamine and norepinephrine by interacting with the serotonin transporter (SERT), dopamine transporter (DAT), and norepinephrine transporter (NET).

One study found that the dissociation constant of naphyrone interacting with SERT is 33.1 ± 1.1 nM, with DAT is 20.1 ± 7.1 nM and with NET is 136 ± 27nM. The concentration of naphyrone required to inhibit the transporters by 50% is 46.0 ± 5.5 nM for SERT, 40.0 ± 13 nM for DAT and 11.7 ± 0.9 nM for NET. Of a number of pyrovalerone analogues tested, naphyrone was found to be the only triple reuptake inhibitor found to be active at nM concentrations.[2]

See also

References

  1. ^ "Deadly New 'Legal' Drug Bound For Britain - Yahoo! News UK". Uk.news.yahoo.com. 2010-03-31. Retrieved 2010-04-03.
  2. ^ a b Meltzer PC, Butler D, Deschamps JR, Madras BK. 1-(4-Methylphenyl)-2-pyrrolidin-1-yl-pentan-1-one (Pyrovalerone) analogues: a promising class of monoamine uptake inhibitors. Journal of Medicinal Chemistry. 2006 Feb 23;49(4):1420-32. PMID 16480278
  3. ^ Alan Travis, home affairs editor (2010-04-01). "NRG-1 may be next legal high to face ban by ministers | Politics". The Guardian. Retrieved 2010-04-03. {{cite news}}: |author= has generic name (help)
  4. ^ Lavery, Michael (2 April 2010). "New 50c legal drug 'is more evil' than any head shop high". The Herald. Retrieved 2 April 2010.
  5. ^ http://www.thesun.co.uk/sol/homepage/features/2984320/Next-meow-meow-to-hit-clubs-and-festivals.html
  6. ^ http://www.drugs-forum.com/forum/local_links.php?action=jump&catid=245&id=9184